Literature DB >> 35559375

Curable congestive heart failure in patients with primary aldosteronism: two cases reports.

Zijun Chen1, Zhe Zhang2, Qianlan Xi3, Guimei Huang1, Liya Wang4.   

Abstract

Primary aldosteronism (PA) is characterized by overproduction of aldosterone which can lead to various target organ damage, including the cardiovascular system. There are rare case reports about PA patients with severe heart failure. We report two male patients who were admitted because of severe cardiac systolic dysfunction induced by primary aldosteronism. Their cardiac function improved significantly after target therapy. Patient A was a 33 year old male with serum aldosterone concentration (PAC) 251.3 pg/ml, renin activity (PRA) 0.04 ng/ml/h, and aldosterone-to-renin ratio (ARR) 627.5. Computed tomography (CT) revealed a tumor in the left adrenal gland, while no dominant secretion function was found in the left side after the adrenal veins sampling (lateralization index 0.99). Bilateral adrenal hyperplasia was diagnosed and spironolactone was prescribed. Left ventricular ejection fraction (LVEF) was improved from 30% to 45% at the 11-month follow-up visit. Patient B was 43 years old male with PAC 185.5 pg/ml, PRA 0.46 ng/ml/h and ARR 403.2; Captopril challenge test was positive and a microadenoma (2.7*3.2*2.8 cm) was revealed on CT. Unilateral aldosterone-producing adenoma was diagnosed. His LVEF was improved from 30% to 51% at 12 months after laparoscopic adrenalectomy. Thus, it is important to screen for PA in patients with heart failure and launch the appropriate treatment for such patients. AJTR
Copyright © 2022.

Entities:  

Keywords:  Heart failure; primary aldosteronism; targeted therapy

Year:  2022        PMID: 35559375      PMCID: PMC9091133     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  30 in total

1.  Cardiac remodeling in patients with primary aldosteronism.

Authors:  F Galetta; G Bernini; F Franzoni; A Bacca; I Fivizzani; L Tocchini; M Bernini; P Fallahi; A Antonelli; G Santoro
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

2.  Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.

Authors:  G P Rossi; A Sacchetto; P Visentin; C Canali; G R Graniero; P Palatini; A C Pessina
Journal:  Hypertension       Date:  1996-05       Impact factor: 10.190

Review 3.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  Circulation       Date:  2017-04-28       Impact factor: 29.690

Review 4.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

5.  Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.

Authors:  Silvia Monticone; Jacopo Burrello; Davide Tizzani; Chiara Bertello; Andrea Viola; Fabrizio Buffolo; Luisa Gabetti; Giulio Mengozzi; Tracy A Williams; Franco Rabbia; Franco Veglio; Paolo Mulatero
Journal:  J Am Coll Cardiol       Date:  2017-04-11       Impact factor: 24.094

Review 6.  Hyperaldosteronism as a common cause of resistant hypertension.

Authors:  David A Calhoun
Journal:  Annu Rev Med       Date:  2012-10-22       Impact factor: 13.739

Review 7.  Aldosterone and cardiovascular disease.

Authors:  Krishna K Gaddam; Eduardo Pimenta; Saima Husain; David A Calhoun
Journal:  Curr Probl Cardiol       Date:  2009-02       Impact factor: 5.200

8.  Outcomes in unilateral primary aldosteronism after surgical or medical therapy.

Authors:  Troy H Puar; Lih M Loh; Wann J Loh; Dawn S T Lim; Meifen Zhang; Pei T Tan; Lynette Lee; Du S Swee; Joan Khoo; Donovan Tay; Sarah Y Tan; Ling Zhu; Linsey Gani; Thomas F King; Peng C Kek; Roger S Foo
Journal:  Clin Endocrinol (Oxf)       Date:  2020-10-26       Impact factor: 3.478

9.  Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.

Authors:  Sébastien Savard; Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

10.  Incidental Congestive Heart Failure in Patients With Aldosterone-Producing Adenomas.

Authors:  Wei-Chieh Huang; Ying-Ying Chen; Yen-Hung Lin; Likwang Chen; Po-Chih Lin; Yu-Feng Lin; Yu-Chun Liu; Che-Hsiung Wu; Jeff S Chueh; Tzong-Shinn Chu; Kwan Dun Wu; Chun-Yao Huang; Vin-Cent Wu
Journal:  J Am Heart Assoc       Date:  2019-12-05       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.